Social Anxiety Disorder Clinical Trial
— STePSOfficial title:
Study of an Internet-delivered Treatment Based on Experiential Dynamic Psychotherapy for Social Anxiety Disorder
NCT number | NCT05015166 |
Other study ID # | STePS |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | August 18, 2021 |
Est. completion date | January 12, 2023 |
Verified date | January 2023 |
Source | Stockholm University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this randomized, controlled study is to examine an internet delivered, self-help program for social anxiety based on psychodynamic therapy. The study will compare three conditions: the psychodynamic program with therapist support, without therapist support and a waitlist control.
Status | Completed |
Enrollment | 181 |
Est. completion date | January 12, 2023 |
Est. primary completion date | January 12, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - 18 years old or older - Fulfill the DSM-5 criteria for social anxiety disorder (Score > 60 on the self-assessment instrument LSAS-SR) - Have access to a computer/smartphone/tablet with internet connection - Be able to read and write Swedish. Exclusion Criteria: - Suicidal (within the previous month, assessed with the self-assessment instrument C-SSRS) - Partaking in psychological treatment - Ongoing treatment with psychopharmacological drugs with dose adjustments within the nearest month or planned dose adjustments. The following self-reported diagnoses are excluded: - Autism spectrum disorder - Serious depression (Score = 20 on the PHQ9) - Indications of psychosis or bipolar disorder (type 1 or 2). |
Country | Name | City | State |
---|---|---|---|
Sweden | Stockholm University | Stockholm |
Lead Sponsor | Collaborator |
---|---|
Stockholm University |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | The Personality Inventory for DSM Short Form (PID-5) | The PID-5 is a self-rated measure of personality-related problems featuring 25 items. | Baseline | |
Other | The Difficulties in Emotion Regulation Scale (DERS) | Features 30 items assessing psychological strategies for handling emotional distress. | Change from baseline to post-treatment (8 week) and follow up (6, 12 and 24 months after treatment) | |
Other | Self-Compassion Scale short-form (SCS-SF) | The SCS-SF features 12 items to record self-compassion towards yourself in difficult life situations. | Change from baseline, week 3 and 6, to post-treatment (8 weeks) and follow up (6, 12 and 24 months after treatment) | |
Other | Defense Mechanism Rating Scale, Self-Report-30 (DMRS-SR-30) | DMRS-SR-30 features 30 items assessing psychological factors that influence emotional distress and quality of life. | Change from baseline to post-treatment (8 week) | |
Other | Reflective Functioning Questionnaire 8 (RFQ-8) | RFQ features 8 items assessing the ability to understand mental states of the self and others. | Change from baseline, treatment week 1-8, to post-treatment (8 weeks). | |
Other | Internet Intervention Patient Adherence Scale | iiPAS is rated by a clinician and features 5 items assessing a particular patient's adherence to internet-delivered psychological interventions. | Change from baseline, and week 4, to post-treatment (8 weeks). | |
Primary | Liebowitz Social Anxiety Scale, Self-Report, (LSAS-SR) | The LSAS-SR features 48 items assessing social anxiety symptoms. | Change from baseline to post-treatment (8 week) and follow up (6, 12 and 24 months after treatment) | |
Secondary | Generalised Anxiety Disorder 7- item scale (GAD-7) | The GAD-7 features seven items for assessing anxiety and screening for generalized anxiety disorder. | Change from baseline to post-treatment (8 week) and follow up (6, 12 and 24 months after treatment) | |
Secondary | Patient Health Questionnaire 9-item scale (PHQ-9) | The PHQ-9 features nine items for assessing depression in a clinical context and screening of depression in the general population | Change from baseline to post-treatment (8 week) and follow up (6, 12 and 24 months after treatment) | |
Secondary | Brunnsviken Brief Quality of Life Scale (BBQ) | The BBQ features 12 items concerning 6 areas of life rated on importance and satisfaction. | Change from baseline to post-treatment (8 week) and follow up (6, 12 and 24 months after treatment) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06274112 -
Using TMS to Understand Neural Processes of Social Motivation
|
N/A | |
Completed |
NCT02554929 -
Treatment of Social Anxiety Disorder and Selective Mutism
|
N/A | |
Completed |
NCT00684541 -
Interpretation Modification Program for Social Phobia
|
N/A | |
Completed |
NCT00684320 -
Attention Disengagement Training for Social Phobia
|
N/A | |
Completed |
NCT03247075 -
Internet-delivered CBT vs Internet-delivered Support and Counseling for Youth With Social Anxiety Disorder - An RCT
|
N/A | |
Completed |
NCT02811458 -
Clinical Trial of Transdiagnostic Cognitive-Behavior Therapy for Anxiety Disorders
|
N/A | |
Withdrawn |
NCT04622930 -
Waitlist-Control Trial of Smartphone CBT for Social Anxiety Disorder (SAD)
|
N/A | |
Active, not recruiting |
NCT05018312 -
Modified Collaborative Assessment VS Standard Assessment on Readiness For Psychotherapy Among Patients With Anxiety
|
N/A | |
Active, not recruiting |
NCT05124639 -
Clinical Trial of a Group Self-management Support Program for Anxiety Disorders
|
N/A | |
Completed |
NCT05858294 -
The Safety, Acceptability and Efficacy of Alena
|
N/A | |
Active, not recruiting |
NCT05600114 -
Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder
|
Phase 2 | |
Not yet recruiting |
NCT06081348 -
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
|
Phase 2 | |
Not yet recruiting |
NCT02924610 -
Brief Intervention to Reduce Fear
|
Phase 4 | |
Active, not recruiting |
NCT02592564 -
Brain Plasticity and Cellular Aging After Internet-delivered CBT for Social Anxiety Disorder
|
N/A | |
Recruiting |
NCT02305537 -
Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment
|
N/A | |
Terminated |
NCT03764644 -
Web-based Attention Bias Modification Treatment for Childhood Anxiety Disorders
|
N/A | |
Unknown status |
NCT01712321 -
Study of Vilazodone to Treat Social Anxiety Disorder
|
N/A | |
Completed |
NCT01320800 -
CBT for Social Anxiety Disorder Delivered by School Counselors
|
Phase 2 | |
Completed |
NCT00773162 -
Flushing in Social Anxiety Disorder on Seroquel
|
Phase 3 | |
Completed |
NCT00485888 -
Flushing in Social Anxiety Disorder on Cipralex
|
Phase 2 |